VALANTINE HANNAH sold 77.3% of their position (25.48K shares) of BRIDGEBIO PHARMA, INC. on the open market
Open‑market sale worth $1.72M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/3/2026ACC: 0001470831-26-000236
-25.48K
Net shares
Net seller
$1.72M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
25.48K acquired · 50.97K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+25.48K
Price / share
$48.45
Trade value
$1.23M
% of position
341.4%
2/27/2026
7.46K→32.95K
Common Stock
Direct
Shares
−14.58K
Price / share
$67.08
Trade value
$978.28K
% of position
44.3%
2/27/2026
32.95K→18.36K
Common Stock
Direct
Shares
−10.90K
Price / share
$67.84
Trade value
$739.50K
% of position
59.4%
2/27/2026
18.36K→7.46K
Total
Net shares
+0.00
Net value
-$483.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2026 | M · Option Exercise | +25.48K | $48.45 | $1.23M | 341.4% | 7.46K | 32.95K |
| Common Stock Direct | 2/27/2026 | S · Sale | −14.58K | $67.08 | $978.28K | 44.3% | 32.95K | 18.36K |
| Common Stock Direct | 2/27/2026 | S · Sale | −10.90K | $67.84 | $739.50K | 59.4% | 18.36K | 7.46K |
| Total | +0.00 | -$483.08K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
25.48K shares
Shares
−25.48K
Strike price
48.45
Held after
0.00
Exercisable
—
2/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock25.48K shares | 2/27/2026 | M · Option Exercise | −25.48K | 48.45 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned398.00
Total
398.00 indirect398.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 398.00 | Indirect |
| Total | 398.00 | 398.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported